Powering India's Manufacturing and Preventive Healthcare Ecosystem

Ayumu Okada, President and CEO, OMRON Healthcare & Junta Tsujinaga, President and CEO, OMRON Corporation

 Powering India's Manufacturing and Preventive Healthcare Ecosystem, Ayumu Okada, Junta Tsujinaga, India Pharma Outlook

During a conference, Ayumu Okada, President and CEO, OMRON Healthcare Co., Ltd., and Junta Tsujinaga, President and CEO, OMRON Corporation, discussed India's growing role as a global manufacturing and innovation hub, the opportunities for industrial automation, and the need to strengthen preventive healthcare. She highlights how digital health solutions, home blood pressure monitoring, and medical technologies can improve early detection of cardiovascular diseases and make preventive care more accessible. She also shares insights on the importance of clinical evidence, regulatory standards, and greater awareness in integrating home blood pressure monitoring into India's healthcare system.

Ayumu Okada has served as President and CEO of OMRON HEALTHCARE Co., Ltd. since 2023 and is also a Managing Executive Officer of OMRON Corporation. She joined OMRON HEALTHCARE in 2007 and has held senior leadership positions across medical product planning, global business strategy, data services, and corporate management. She was appointed Executive Officer in 2021 and Managing Executive Officer in 2023.

Junta Tsujinaga has served as President and CEO of OMRON Corporation since April 2023. He joined the company in 1989 and has held several senior leadership positions across its Industrial Automation business. He was appointed Executive Officer in 2017 and Managing Executive Officer in 2019. In 2021, he became Company President of OMRON's Industrial Automation Company before taking over as President and CEO of OMRON Corporation in 2023.

India is emerging as a global manufacturing hub. What opportunities do you see for the country's industrial sector, and how can automation support this transformation?

India is facing historic opportunities, geopolitical change, strong government industry policy, and rapidly expanding domestic demand. In particular, advanced industries supported by government initiatives are expected to expand rapidly. India is no longer only a large market. It's becoming a global hub for manufacturing and innovation.

Semiconductors, EVs, batteries, and electronics are driving this transformation. India will play a bigger role in the global supply chain and in the future of technology. With our automation technology and global expertise, we help manufacturing improve quality, productivity, and sustainability.

Our message is very simple. From Make in India to Innovate in India. Together, we will help create world-class manufacturing in India.  

India faces significant healthcare challenges, including hypertension. How can technology and digital health help strengthen preventive healthcare?

India is experiencing rapid economic growth. At the same time, it faces serious health challenges. One of the most urgent challenges is hypertension. High blood pressure can lead to heart disease, stroke, kidney disease, and other serious conditions.

It affects not only individuals and families, but also healthcare costs and the vitality of society. People need to monitor their health regularly, identify risks early, and take action before illness develops. Through blood pressure monitors, ECG, and our collaboration with Tricog, Omron will help make preventive care more accessible across India.

We will continue to build a data-based foundation that protects the health of people in India. Health data collected at home, in communities, and at medical institutions can be connected to healthcare services.

The key words are preventive medicine through digital health and longer, healthy lives. Everyone can live long, healthy, and fulfilling lives regardless of where they live or their income.

What changes do you expect in India's manufacturing and healthcare landscape as the country continues to grow?

India is no longer only a large market. It's becoming a global hub for manufacturing and innovation. India will play a bigger role in the global supply chain and in the future of technology.

At the same time, India is experiencing rapid economic growth, and healthcare is an important part of the country's future. People need to monitor their health regularly, identify risks early, and take action before illness develops.

Through automation technology, we can help manufacturing improve quality, productivity, and sustainability. Through digital health, we can help make preventive care more accessible across India.

India is witnessing a shift in its healthcare priorities, with cardiovascular diseases emerging as a major concern. What are the key challenges, and why is preventive healthcare becoming increasingly important?

As India's economy continues to grow, people's lives and lifestyles are changing. In the past, infectious diseases were a major health concern in India, but today, according to WHO data, cardiovascular diseases are the leading cause of death in India, followed by respiratory diseases.

What makes cardiovascular diseases particularly challenging is that they often develop over many years. Risk factors such as high blood pressure can go unnoticed for a long time, even as the risk of serious illness increases. That is why prevention is so important.

High blood pressure is often called the silent killer. It often develops without noticeable symptoms, yet it can lead to serious conditions such as stroke, heart failure, and kidney disease. An estimated 300 million people in India are living with high blood pressure today, and that number is expected to grow. That is why it is so important to take action before symptoms appear.

Also Read: India's Role in Shaping the Future of Oncology and Immunology

High blood pressure often goes undetected. How can regular home blood pressure monitoring help people identify risks early and manage their health better?

The first step in managing high blood pressure is to know your own blood pressure. However, because blood pressure can fluctuate significantly throughout the day, a single measurement may not give us the full picture.

What makes this even more challenging is that some types of high blood pressure are particularly difficult to detect. For example, with masked hypertension, blood pressure may be normal at the doctor's office, but high at home. There is also morning hypertension, when blood pressure rises in the morning.

That is why we believe it's so important to measure blood pressure regularly at home and share the results with doctors. By doing so, people can better understand blood pressure and identify potential risks before serious health problems develop.

For more than 50 years, Omron Healthcare has worked to bring blood pressure monitoring into people's homes. Since launching our first home blood pressure monitor in 1973, our goal has always been to make it possible for people to manage their health at home.

So far, we have delivered more than 400 million blood pressure monitors worldwide. Our monitors are used in more than 130 countries and regions.

How can medical devices, digital health solutions, and public awareness initiatives make preventive healthcare more accessible?

Alongside home blood pressure monitoring, we are also working to detect atrial fibrillation early, which is a heart rhythm condition that increases the risk of stroke.

We have developed devices that make it easy to record an ECG at home. We also have technologies that can detect possible atrial fibrillation during a blood pressure measurement.

Alongside providing blood pressure monitors, we also want to help people understand why measuring blood pressure at home is so important.

One way we do this is through health camps held in public spaces and pharmacies, where people can have their blood pressure measured and learn more about their health. So far, more than 25,000 people have taken part in these events.

We also work with the next generation of doctors by offering lectures to medical students on the importance of home blood pressure monitoring. So far, 2,600 students have taken part in these lectures. We also take part in India's family adoption program, through which medical students can share health information and explain why regular blood pressure checks at home matter.

Through all these activities, we are working towards the same goal of making home blood pressure monitoring part of everyday life for more people across India.

What is needed to establish home blood pressure monitoring as a reliable part of clinical practice in India?

To make home blood pressure monitoring a more common part of everyday healthcare, we need clinical evidence demonstrating its value in medical practice.

In India, 90 experts from the Indian Society came together to develop the country's first guidelines for measuring blood pressure at home.

The guidelines are based on data from around 1,900 cases collected at 18 medical facilities across 12 states. Omron Healthcare supported this work by providing blood pressure monitors and helping with clinical research.

These guidelines provide a foundation for using home blood pressure readings to help guide treatment for high blood pressure.

For home blood pressure readings to be used in clinical practice, doctors need to be confident in their accuracy. This is why blood pressure monitors, as medical devices, must meet the regulatory requirements of each country.

Home blood pressure monitors are approved as medical devices in 97 countries, and India is no exception. Building on this trust, we aim to further expand home blood pressure monitoring across India by providing accurate and reliable products.

on the deck

Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

Editor's Guest

Related Articles

© 2026 India Pharma Outlook. All Rights Reserved.